We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Butterfly Wings-Inspired Imaging Technique Enables Faster Cancer Diagnosis

By LabMedica International staff writers
Posted on 24 Feb 2025

Fibrosis, which refers to the accumulation of fibrous tissue, is a significant characteristic of various diseases, including neurodegenerative conditions, heart disease, and cancer. More...

In oncology, determining the extent of fibrosis in a biopsy can help assess whether a cancer is in its early or advanced stages. However, distinguishing between these stages using current clinical methods is a significant challenge. These methods typically involve staining tissues to highlight key structures in a tumor biopsy, but the results can be subjective—interpretations may vary between pathologists. While more advanced imaging techniques can provide more detailed insights, they often require expensive, specialized equipment that is not available in many clinics. Now, researchers have discovered an unexpected ally in the effort to make cancer diagnosis faster, more accurate, and more accessible worldwide: the Morpho butterfly.

Renowned for its vibrant blue wings, the Morpho butterfly’s brilliance is not due to pigments but to microscopic structures that manipulate light. Researchers at the University of California San Diego (La Jolla, CA, USA) are utilizing these same microstructures to gain detailed insights into the fibrous composition of cancer biopsy samples—without the need for chemical stains or costly imaging systems. In a study published in Advanced Materials, the team demonstrated that by placing a biopsy sample atop a Morpho butterfly wing and observing it under a standard microscope, they could determine whether the tumor’s structure suggests early- or late-stage cancer—without relying on staining or expensive imaging devices. The micro- and nanostructures of the wing interact strongly with polarized light, a type of light that moves in a specific direction. Collagen fibers, which are a vital component of fibrotic tissue, also respond to polarized light, though their signals are weak. By positioning a biopsy sample over a section of a Morpho butterfly wing, the researchers amplified these weak signals, making it easier to examine the density and arrangement of collagen fibers.

The amplified signals can then be interpreted to quantify the density and organization of the collagen fibers in the sample. To achieve this, the researchers developed a mathematical model based on Jones calculus, a technique used to analyze polarized light. The model correlates the intensity of the light with the density and structure of collagen fibers, providing a measurable indicator of fibrosis in the tissue. The researchers applied this method to analyze both collagen-dense and collagen-sparse human breast cancer biopsy samples. Their findings were comparable to conventional staining techniques and a high-cost advanced imaging method. Importantly, this technique can be performed with standard optical microscopes that are already available in most clinics. Additionally, it is more objective and quantitative than existing methods. Although this study focused on breast cancer, the researchers believe this approach could be extended to other fibrotic diseases as well.

“Essentially, we’re trying to expand on these procedures with a stain-free alternative that requires nothing more than a standard optical microscope and a piece of a Morpho wing,” said Paula Kirya, a mechanical engineering graduate student at UC San Diego and the study’s first author. “In many parts of the world, early cancer screening is a challenge because of resource limitations. If we can provide a simpler and more accessible tool, we can help more patients get diagnosed before their cancers reach aggressive stages.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.